Celsius Therapeutics Company

Celsius Therapeutics develop life-changing medicines and discover critical biomarkers for patient care by better understanding the cellular ecosystem of diseases through Single Cell Genomics and Machine Learning.
Technology: Biotechnology, Emergency Medicine, Genetics, Health Care
Industry: Early Drug Development
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2018-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: 65000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-05-15
Last Funding Type: Series A

Visit Website
info@celsiustx.com
https://twitter.com/celsiustx
Register and Claim Ownership